The therapy of cushing's disease in adults and children: An update

Hormone and Metabolic Research

Volumn 45, Issue 2, 2013, Pages 109-117

  Juszczak, A ^a   Ertorer, M E ^b   Grossman, A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

ACTH; HPA axis; hypercortisolism

Indexed keywords

AMINOTRANSFERASE; CABERGOLINE; DEXAMETHASONE; ETOMIDATE; GLUCOCORTICOID RECEPTOR ANTAGONIST; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE; MIFEPRISTONE; MITOTANE; PASIREOTIDE; ROSIGLITAZONE;

ACNE; ADRENALECTOMY; ADULT DISEASE; ALOPECIA; ANGIONEUROTIC EDEMA; ARTHRALGIA; ATAXIA; CHILDHOOD DISEASE; CHOLELITHIASIS; CUSHING DISEASE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DIARRHEA; DISEASE CONTROL; DISEASE SEVERITY; DIZZINESS; DRUG ERUPTION; DRUG INDUCED HEADACHE; DYSPEPSIA; EDEMA; ENDOMETRIAL THICKNESS; EVENING DOSAGE; EXTERNAL BEAM RADIOTHERAPY; GAMMA KNIFE; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HALLUCINATION; HEADACHE; HIRSUTISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCHOLESTEROLEMIA; HYPERCORTISOLISM; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LETHARGY; LIBIDO; LIVER TOXICITY; LONG TERM CARE; NAUSEA; NAUSEA AND VOMITING; NELSON SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PETROSAL SINUS SAMPLING; PRIORITY JOURNAL; RADIATION DOSE; RADIOSURGERY; RECURRENCE RISK; REMISSION; REVIEW; SEDATION; SIDE EFFECT; STEROIDOGENESIS; TERATOGENICITY; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; TRANSSPHENOIDAL HYPOPHYSECTOMY; TRANSSPHENOIDAL SURGERY; TREATMENT RESPONSE; TUMOR RECURRENCE; VERTIGO; VOMITING; WELLBEING;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADRENALECTOMY; ADRENERGIC ANTAGONISTS; ADULT; CHILD; COMBINED MODALITY THERAPY; DECISION TREES; ENZYME INHIBITORS; HORMONE ANTAGONISTS; HUMANS; PITUITARY ACTH HYPERSECRETION; RADIOSURGERY;

EID: 84874107525     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1330009     Document Type: Review

References (74)

1. Newell-Price J., Bertagna X., Grossman A. B., Nieman L. K. Cushing's syndrome. Lancet: 2006; 367 1605 1617
2. Juszczak A., Grossman A. The investigation of cushing syndrome: essentials in optimizing appropriate diagnosis and management. Ann Saudi Med: 2012; 32 455 461
3. Biller B. M., Grossman A. B., Stewart P. M., Melmed S., Bertagna X., Bertherat J., Buchfelder M., Colao A., Hermus A. R., Hofland L. J., Klibanski A., Lacroix A., Lindsay J. R., Newell-Price J., Nieman L. K., Petersenn S., Sonino N., Stalla G. K., Swearingen B., Vance M. L., Wass J. A., Boscaro M. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab: 2008; 93 2454 2462
4. Kaltsas G. A., Giannulis M. G., Newell-Price J. D., Dacie J. E., Thakkar C., Afshar F., Monson J. P., Grossman A. B., Besser G. M., Trainer P. J. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab: 1999; 84 487 492
5. Sahdev A., Reznek R. H., Evanson J., Grossman A. B. Imaging in Cushing's syndrome. Arq Bras Endocrinol Metabol: 2007; 51 1319 1328
6. Trainer P. J., Lawrie H. S., Verhelst J., Howlett T. A., Lowe D. G., Grossman A. B., Savage M. O., Afshar F., Besser G. M. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf): 1993; 38 73 78
7. Valassi E., Biller B. M., Swearingen B., Pecori Giraldi F., Losa M., Mortini P., Hayden D., Cavagnini F., Klibanski A. Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab: 2010; 95 601 610
8. Hassan-Smith Z. K., Sherlock M., Reulen R. C., Arlt W., Ayuk J., Toogood A. A., Cooper M. S., Johnson A. P., Stewart P. M. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab: 2012; 97 1194 1201
9. Hofmann B. M., Fahlbusch R. Treatment of Cushing's disease: a retrospective clinical study of the latest 100 cases. Front Horm Res: 2006; 34 158 184
10. Storr H. L., Alexandraki K. I., Martin L., Isidori A. M., Kaltsas G. A., Monson J. P., Besser G. M., Matson M., Evanson J., Afshar F., Sabin I., Savage M. O., Grossman A. B. Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease. Eur J Endocrinol: 2011; 164 667 674
11. Atkinson A. B., Kennedy A., Wiggam M. I., McCance D. R., Sheridan B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin Endocrinol (Oxf): 2005; 63 549 559
12. Swearingen B., Biller B. M., Barker F. G. 2nd, Katznelson L., Grinspoon S., Klibanski A., Zervas N. T. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med: 1999; 130 821 824
13. Blevins L. S. Jr, Christy J. H., Khajavi M., Tindall G. T. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab: 1998; 83 63 67
14. Benveniste R. J., King W. A., Walsh J., Lee J. S., Delman B. N., Post K. D. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg: 2005; 102 1004 1012
15. Hofmann B. M., Hlavac M., Kreutzer J., Grabenbauer G., Fahlbusch R. Surgical treatment of recurrent Cushing's disease. Neurosurgery. 2006; 58 1108 1118 discussion 1108-1118
16. Minniti G., Brada M. Radiotherapy and radiosurgery for Cushing's disease. Arq Bras Endocrinol Metabol: 2007; 51 1373 1380
17. Leber K. A., Bergloff J., Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg: 1998; 88 43 50
18. Minniti G., Osti M., Jaffrain-Rea M. L., Esposito V., Cantore G., Maurizi Enrici R. Long term follow-up results of postoperative radiation therapy for Cushing's disease. J Neurooncol: 2007; 84 79 84
19. Estrada J., Boronat M., Mielgo M., Magallon R., Millan I., Diez S., Lucas T., Barcelo B. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med: 1997; 336 172 177
20. Castinetti F., Nagai M., Dufour H., Kuhn J. M., Morange I., Jaquet P., Conte-Devolx B., Regis J., Brue T. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. Eur J Endocrinol: 2007; 156 91 98
21. Jagannathan J., Sheehan J. P., Pouratian N., Laws E. R., Steiner L., Vance M. L. Gamma Knife surgery for Cushing's disease. J Neurosurg: 2007; 106 980 987
22. Gil-Cardenas A., Herrera M. F., Diaz-Polanco A., Rios J. M., Pantoja J. P. Nelson's syndrome after bilateral adrenalectomy for Cushing's disease. Surgery. 2007; 141 147 151 discussion 142- 151
23. Jenkins P. J., Trainer P. J., Plowman P. N., Shand W. S., Grossman A. B., Wass J. A., Besser G. M. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab: 1995; 80 165 171
24. Grossman A. B. Clinical Review: The diagnosis and management of central hypoadrenalism. J Clin Endocrinol Metab: 2010; 95 4855 4863
25. Barber T. M., Adams E., Ansorge O., Byrne J. V., Karavitaki N., Wass J. A. Nelson's syndrome. Eur J Endocrinol: 2010; 163 495 507
26. Assie G., Bahurel H., Coste J., Silvera S., Kujas M., Dugue M. A., Karray F., Dousset B., Bertherat J., Legmann P., Bertagna X. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome. J Clin Endocrinol Metab: 2007; 92 172 179
27. Verhelst J. A., Trainer P. J., Howlett T. A., Perry L., Rees L. H., Grossman A. B., Wass J. A., Besser G. M. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf): 1991; 35 169 178
28. Praw S. S., Heaney A. P. Medical treatment of Cushing's disease: Overview and recent findings. Int J Gen Med: 2009; 2 209 217
29. Castinetti F., Morange I., Jaquet P., Conte-Devolx B., Brue T. Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease. Eur J Endocrinol: 2008; 158 91 99
30. Sonino N., Boscaro M., Paoletta A., Mantero F., Ziliotto D. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol (Oxf): 1991; 35 347 352
31. Alexandraki K. I., Kaltsas G. A., le Roux C. W., Fassnacht M., Ajodha S., Christ-Crain M., Akker S. A., Drake W. M., Edwards R., Allolio B., Grossman A. B. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. Clin Endocrinol (Oxf): 2010; 72 305 311
32. Terzolo M., Pia A., Berruti A., Osella G., Ali A., Carbone V., Testa E., Dogliotti L., Angeli A. Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab: 2000; 85 2234 2238
33. Dang C. N., Trainer P. Pharmacological management of Cushing's syndrome: an update. Arq Bras Endocrinol Metabol: 2007; 51 1339 1348
34. Kamenicky P., Droumaguet C., Salenave S., Blanchard A., Jublanc C., Gautier J. F., Brailly-Tabard S., Leboulleux S., Schlumberger M., Baudin E., Chanson P., Young J. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab: 2011; 96 2796 2804
35. Schulte H. M., Benker G., Reinwein D., Sippell W. G., Allolio B. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose response relationship in normal subjects. J Clin Endocrinol Metab: 1990; 70 1426 1430
36. Preda V. A., Sen J., Karavitaki N., Grossman A. Etomidate in the Management of Hypercortisolaemia in Cushing's Syndrome. Eur J Endocrinol: 2012; 167 137 143
37. Fleseriu M., Biller B. M., Findling J. W., Molitch M. E., Schteingart D. E., Gross C. Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome. J Clin Endocrinol Metab: 2012; 97 2039 2049
38. Castinetti F., Conte-Devolx B., Brue T. Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone. Neuroendocrinology: 2010; 92 01 125 130
39. Pivonello R., Ferone D., de Herder W. W., Kros J. M., De Caro M. L., Arvigo M., Annunziato L., Lombardi G., Colao A., Hofland L. J., Lamberts S. W. Dopamine receptor expression and function in corticotroph pituitary tumors. J Clin Endocrinol Metab: 2004; 89 2452 2462
40. Miller JW, Crapo L. The medical treatment of Cushing's syndrome. Endocr Rev: 1993; 14 443 458
41. Vilar L., Naves L. A., Azevedo M. F., Arruda M. J., Arahata C. M., Moura ES L., Agra R., Pontes L., Montenegro L., Albuquerque J. L., Canadas V. Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease. Pituitary: 2010; 13 123 129
42. Boscaro M., Ludlam W. H., Atkinson B., Glusman J. E., Petersenn S., Reincke M., Snyder P., Tabarin A., Biller B. M., Findling J., Melmed S., Darby C. H., Hu K., Wang Y., Freda P. U., Grossman A. B., Frohman L. A., Bertherat J. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab: 2009; 94 115 122
43. Colao A., Petersenn S., Newell-Price J., Findling J. W., Gu F., Maldonado M., Schoenherr U., Mills D., Salgado L. R., Biller B. M. A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med: 2012; 366 914 924
44. Pecori Giraldi F., Scaroni C., Arvat E., Martin M., Giordano R., Albiger N., Leao A. A., Picu A., Mantero F., Cavagnini F. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clin Endocrinol (Oxf): 2006; 64 219 224
45. Suri D., Weiss R. E. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease. J Clin Endocrinol Metab: 2005; 90 1340 1346
46. Storr H. L., Isidori A. M., Monson J. P., Besser G. M., Grossman A. B., Savage M. O. Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab: 2004; 89 3818 3820
47. Magiakou M. A., Mastorakos G., Oldfield E. H., Gomez M. T., Doppman J. L., Cutler G. B. Jr, Nieman L. K., Chrousos G. P. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med: 1994; 331 629 636
48. Dupuis C. C., Storr H. L., Perry L. A., Ho J. T., Ahmed L., Ong K. K., Dunger D. B., Monson J. P., Grossman A. B., Besser G. M., Savage M. O. Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations. Clin Endocrinol (Oxf). 2007; 66 838 843
49. Newell-Price J., Trainer P., Besser M., Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev: 1998; 19 647 672
50. Devoe D. J., Miller W. L., Conte F. A., Kaplan S. L., Grumbach M. M., Rosenthal S. M., Wilson C. B., Gitelman S. E. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab: 1997; 82 3196 3202
51. Styne D. M., Grumbach M. M., Kaplan S. L., Wilson C. B., Conte F. A. Treatment of Cushing's disease in childhood and adolescence by transsphenoidal microadenomectomy. N Engl J Med: 1984; 310 889 893
52. Weber A., Trainer P. J., Grossman A. B., Afshar F., Medbak S., Perry L. A., Plowman P. N., Rees L. H., Besser G. M., Savage M. O. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome. Clin Endocrinol (Oxf): 1995; 43 19 28
53. Oliveira R. S., Castro M., Antonini S. R., Martinelli C. E. Jr, Moreira A. C., Machado H. R. Surgical management of pediatric Cushing's disease: an analysis of 15 consecutive cases at a specialized neurosurgical center. Arq Bras Endocrinol Metabol: 2010; 54 17 23
54. Buchfelder M., Fahlbusch R. Neurosurgical treatment of Cushing's disease in children and adolescents. Acta Neurochir Suppl (Wien): 1985; 35 101 105
55. Batista D., Courkoutsakis N. A., Oldfield E. H., Griffin K. J., Keil M., Patronas N. J., Stratakis C. A. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease. J Clin Endocrinol Metab: 2005; 90 5134 5140
56. Dias R. P., Kumaran A., Chan L. F., Martin L., Afshar F., Matson M., Plowman P. N., Monson J. P., Besser G. M., Grossman A. B., Savage M. O., Storr H. L. Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease. Eur J Endocrinol: 2010; 162 603 609
57. Lienhardt A., Grossman A. B., Dacie J. E., Evanson J., Huebner A., Afshar F., Plowman P. N., Besser G. M., Savage M. O. Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH dependent Cushing's syndrome. J Clin Endocrinol Metab: 2001; 86 5711 5714
58. Batista D., Gennari M., Riar J., Chang R., Keil M. F., Oldfield E. H., Stratakis C. A. An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. J Clin Endocrinol Metab: 2006; 91 221 224
59. Storr H. L., Afshar F., Matson M., Sabin I., Davies K. M., Evanson J., Plowman P. N., Besser G. M., Monson J. P., Grossman A. B., Savage M. O. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. Eur J Endocrinol: 2005; 152 825 833
60. Joshi S. M., Hewitt R. J., Storr H. L., Rezajooi K., Ellamushi H., Grossman A. B., Savage M. O., Afshar F. Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical center. Neurosurgery. 2005; 57 281 285 discussion 281-285
61. Leinung M. C., Kane L. A., Scheithauer B. W., Carpenter P. C., Laws E. R. Jr, Zimmerman D. Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. J Clin Endocrinol Metab: 1995; 80 2475 2479
62. Storr H. L., Plowman P. N., Carroll P. V., Francois I., Krassas G. E., Afshar F., Besser G. M., Grossman A. B., Savage M. O. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment. J Clin Endocrinol Metab: 2003; 88 34 37
63. Lodish M., Dunn S. V., Sinaii N., Keil M. F., Stratakis C. A. Recovery of the hypothalamic pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease. J Clin Endocrinol Metab: 2012; 97 1483 1491
64. Batista D. L., Oldfield E. H., Keil M. F., Stratakis C. A. Postoperative testing to predict recurrent Cushing's disease in children. J Clin Endocrinol Metab: 2009; 94 2757 2765
65. McCance D. R., Russell C. F., Kennedy T. L., Hadden D. R., Kennedy L., Atkinson A. B. Bilateral adrenalectomy: low mortality and morbidity in Cushing's disease. Clin Endocrinol (Oxf): 1993; 39 315 321
66. Lebrethon M. C., Grossman A. B., Afshar F., Plowman P. N., Besser G. M., Savage M. O. Linear growth and final height after treatment for Cushing's disease in childhood. J Clin Endocrinol Metab: 2000; 85 3262 3265
67. Greening J. E., Brain C. E., Perry L. A., Mushtaq I., Sales Marques J., Grossman A. B., Savage M. O. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease. Horm Res: 2005; 64 140 143
68. Chan L. F., Vaidya M., Westphal B., Allgrove J., Martin L., Afshar F., Hindmarsh P. C., Savage M. O., Grossman A. B., Storr H. L. Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease. Horm Res Paediatr: 2011; 75 441 446
69. Knappe U. J., Ludecke D. K. Transnasal microsurgery in children and adolescents with Cushing's disease. Neurosurgery. 1996; 39 484 492 discussion 483-492
70. Chan L. F., Storr H. L., Plowman P. N., Perry L. A., Besser G. M., Grossman A. B., Savage M. O. Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. Eur J Endocrinol: 2007; 156 477 482
71. Nicholl R. M., Kirk J. M., Grossman A. B., Plowman P. N., Besser G. M., Savage M. O. Acceleration of pubertal development following pituitary radiotherapy for Cushing's disease. Clin Oncol (R Coll Radiol): 1993; 5 393 394
72. Magiakou M. A., Mastorakos G., Chrousos G. P. Final stature in patients with endogenous Cushing's syndrome. J Clin Endocrinol Metab: 1994; 79 1082 1085
73. Johnston L. B., Grossmann A. B., Plowman P. N., Besser G. M., Savage M. O. Normal final height and apparent cure after pituitary irradiation for Cushing's disease in childhood: long-term follow-up of anterior pituitary function. Clin Endocrinol (Oxf): 1998; 48 663 667
74. Davies J. H., Storr H. L., Davies K., Monson J. P., Besser G. M., Afshar F., Plowman P. N., Grossman A., Savage M. O. Final adult height and body mass index after cure of paediatric Cushing's disease. Clin Endocrinol (Oxf): 2005; 62 466 472